• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vibrosense Dynamics

0.78 SEK+5.14 %16.7, 17.29
Less than 1K followers

VSD B

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.14 %
-7.60 %
+8.06 %
-1.27 %
-16.16 %
-51.68 %
-78.39 %
-90.73 %
-80.45 %

Vibrosense Dynamics operates in the medical technology sector. The company develops products and services for diagnostic support in nerve damage. The products measure the ability to feel vibrations in the skin, and are used by healthcare providers to be able to adapt treatment or take preventive measures in the event of potential nerve damage. The company's customers mainly consist of diabetes clinics, hospitals, health centers and research institutes. Vibrosense Dynamics was founded in 2005 and is headquartered in Malmö.

Read more
Market cap
25.83M SEK
Turnover
75.57K SEK
Revenue
2.2M
EBIT %
-225.91 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
14.8
2026

Interim report Q2'26

6.10
2026

Interim report Q3'26

19.2
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release07.07.2026, 09.12

VibroSense: Initiates legal negotiations with the company's Chinese distributor over breach of contract

Vibrosense Dynamics
Regulatory press release01.07.2026, 08.30

VibroSense Meter® II Receives Regulatory Approval in Turkey

Vibrosense Dynamics
Regulatory press release18.06.2026, 08.47

VibroSense: Signs a distribution agreement with Fu Kang Healthcare in Singapore

Vibrosense Dynamics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release09.06.2026, 13.31

New Research: Diabetic Neuropathy Can Be Reversed?

Vibrosense Dynamics
Regulatory press release25.05.2026, 11.26

VibroSense: Receives regulatory approval in Singapore

Vibrosense Dynamics
Regulatory press release18.05.2026, 08.30

VibroSense: Signs Distribution Agreement with Sparqmed in Poland

Vibrosense Dynamics
Regulatory press release29.04.2026, 08.30

VibroSense: Signs Distribution Agreement with Alpmed in Turkey

Vibrosense Dynamics
Regulatory press release21.04.2026, 08.30

VibroSense: Granted Patent in Japan - Biomarker for prediction of chemotherapy induced peripheral neuropathy

Vibrosense Dynamics
Regulatory press release29.12.2025, 08.30

VibroSense: Begins research collaboration with the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust in the UK

Vibrosense Dynamics
Regulatory press release18.12.2025, 08.30

VibroSense continues its international market establishment

Vibrosense Dynamics
Regulatory press release06.11.2025, 13.00

VibroSense Dynamics announces delayed deliveries to China

Vibrosense Dynamics
Regulatory press release17.10.2025, 08.30

VibroSense: Interim report 5 for the period 1 July 2025 - 30 September 2025

Vibrosense Dynamics
Regulatory press release09.09.2025, 11.18

Newsletter - VibroSense Dynamics AB strengthens its organisation and prepares for launch in China

Vibrosense Dynamics
Regulatory press release01.08.2025, 13.14

VibroSense: Obtains patent on Biomarker to predict the risk of getting nerve damage during cancer treatment with chemotherapy

Vibrosense Dynamics
Regulatory press release19.06.2025, 10.36

VibroSense receives a formal NMPA certificate - three-year agreement with UMCare worth 3.74 million euros enters into force

Vibrosense Dynamics
Regulatory press release28.05.2025, 13.11

VibroSense Dynamics enters research collaboration with Complutense University of Madrid

Vibrosense Dynamics
Regulatory press release21.05.2025, 14.21

VibroSense Dynamics AB Receives NMPA Approval for VibroSense Meter® II in China

Vibrosense Dynamics